News & Updates
Filter by Specialty:
Antihypertensive drugs confer durable BP reduction in white-coat hypertension
Antihypertensive medications prove to be effective and lasting in decreasing office blood pressure (BP) among individuals with white-coat hypertension (WCH), suggests a study.
Antihypertensive drugs confer durable BP reduction in white-coat hypertension
11 Sep 2022Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
Despite having no such history, about a third of patients with Parkinson’s disease (PD) show evidence of thrombocytopaenia or platelet dysfunction, reports a recent study.
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
10 Sep 2022Cathepsin S levels predict survival in NSTE-ACS patients
Circulating cathepsin S (CTSS) is significantly associated with long-term mortality and may be used to enhance risk stratification of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) over the Global Registry of Acute Coronary Events (GRACE) risk score, suggests a study.
Cathepsin S levels predict survival in NSTE-ACS patients
09 Sep 2022Slow progress to heart failure, death seen in patients with d-TGA after atrial switch
Most adults with d-loop transposition of the great arteries (d-TGA) after atrial switch operation exhibit slow progression to end-stage heart failure or death, according to a recent study.
Slow progress to heart failure, death seen in patients with d-TGA after atrial switch
09 Sep 2022Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.